Aurinia Pharmaceuticals (AUPH) Shares Outstanding (Diluted Average) (2020 - 2026)

Aurinia Pharmaceuticals has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $137.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 3.88% year-over-year to $137.6 million; the trailing twelve-month figure through Mar 2026 stood at $137.6 million (down 3.88% YoY), and the FY2025 full-year result was $138.7 million, down 5.13% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $137.6 million, down from $138.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $146.2 million in Q4 2024, with the low at $136.0 million in Q3 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $141.9 million across 5 years, with a median of $142.6 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) gained 11.2% — and 2025, when it decreased 6.62%.
• Aurinia Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $141.9 million in 2022, then increased by 0.93% to $143.2 million in 2023, then increased by 2.07% to $146.2 million in 2024, then decreased by 5.13% to $138.7 million in 2025, then declined by 0.76% to $137.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $137.6 million (Q1 2026), $138.7 million (Q4 2025), and $136.0 million (Q3 2025), per Business Quant data.